{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:22:21Z","timestamp":1763036541227},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2010,9,8]],"date-time":"2010-09-08T00:00:00Z","timestamp":1283904000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s00108-010-2720-4","type":"journal-article","created":{"date-parts":[[2010,9,6]],"date-time":"2010-09-06T12:21:17Z","timestamp":1283775677000},"page":"1267-1280","source":"Crossref","is-referenced-by-count":5,"title":["Sj\u00f6gren-Syndrom"],"prefix":"10.1007","volume":"51","author":[{"given":"A.","family":"Hansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"D\u00f6rner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,8]]},"reference":[{"key":"2720_CR1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2174\/187152810791292935","volume":"9","author":"Becker","year":"2010","unstructured":"Becker H, Pavenstaedt H, Willeke P (2010) Ermerging treatment strategies and potential therapeutic targets in primary Sj\u00f6gren\u2019s syndrome. Inflamm Allergy Drug Targets 9:10\u201319","journal-title":"Inflamm Allergy Drug Targets"},{"key":"2720_CR2","doi-asserted-by":"crossref","unstructured":"Brucato A (2008) Prevention of congenital heart block in children of SSA-positive mothers. Rheumatology (Oxford) 47(Suppl 3):iii35\u2013iii37","DOI":"10.1093\/rheumatology\/ken153"},{"key":"2720_CR3","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/jcp.21.5.656","volume":"21","author":"Cisholm","year":"1968","unstructured":"Cisholm DM, Mason DK (1968) Labial salivary gland biopsy in Sj\u00f6gren\u2019s disease. J Clin Pathol 21(5):656\u2013660","journal-title":"J Clin Pathol"},{"key":"2720_CR4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/BOR.0b013e32832a0760","volume":"21","author":"Daridon","year":"2009","unstructured":"Daridon C, Burmester GR, D\u00f6rner T (2009) Anticytokine therapy impacting on B cells in autoimmune diseases. Curr Opin Rheumatol 21:205\u2013210","journal-title":"Curr Opin Rheumatol"},{"key":"2720_CR5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","volume":"366","author":"Fox","year":"2005","unstructured":"Fox R (2005) Sj\u00f6gren\u2019s syndrome. Lancet 366:321\u2013331","journal-title":"Lancet"},{"key":"2720_CR6","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/01.bor.0000172801.56744.c3","volume":"17","author":"Hansen","year":"2005","unstructured":"Hansen A, Lipsky PE, D\u00f6rner T (2005) Immunopathogenesis of primary Sj\u00f6gren\u2019s syndrome: implications for disease management and therapy. Curr Opin Rheumatol 17:558\u2013565","journal-title":"Curr Opin Rheumatol"},{"key":"2720_CR7","doi-asserted-by":"crossref","first-page":"R218","DOI":"10.1186\/ar2210","volume":"9","author":"Hansen","year":"2007","unstructured":"Hansen A, Lipsky PE, D\u00f6rner T (2007) B cells in Sj\u00f6gren\u2019s syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue. Arthritis Res Ther 9:R218","journal-title":"Arthritis Res Ther"},{"key":"2720_CR8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/ncprheum0620","volume":"3","author":"Hansen","year":"2007","unstructured":"Hansen A, Lipsky PE, D\u00f6rner T (2007) B-cell lymphoproliferation in chronic inflammatory rheumatic diseases. Nat Clin Pract Rheumatol 3:561\u2013569","journal-title":"Nat Clin Pract Rheumatol"},{"key":"2720_CR9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00393-009-0515-6","volume":"69","author":"Hansen","year":"2010","unstructured":"Hansen A, Feist E (2010) Kritischer \u00dcberblick zu Outcome-Parametern bei Patienten mit prim\u00e4rem Sj\u00f6gren-Syndrom. Z Rheumatol 69:25\u201331","journal-title":"Z Rheumatol"},{"key":"2720_CR10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00393-009-0515-6","volume":"69","author":"Hansen","year":"2010","unstructured":"Hansen A, D\u00f6rner T (2010) Aktuelle therapeutische Optionen bei Sj\u00f6gren-Syndrom. Z Rheumatol 69:19\u201324","journal-title":"Z Rheumatol"},{"key":"2720_CR11","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.autrev.2010.05.005","volume":"9","author":"Hansen","year":"2010","unstructured":"Hansen A, Daridon C, D\u00f6rner T (2010) What do we know about memory B cells in primary Sj\u00f6gren\u2019s syndrome. Autoimmun Rev 9:600\u2013603","journal-title":"Autoimmun Rev"},{"key":"2720_CR12","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1470-2045(04)01490-1","volume":"5","author":"Hennessy","year":"2004","unstructured":"Hennessy BT, Hanrahan EO, Daly P (2004) Non-Hodgkin lymphoma: an update. Lancet Oncol 5:341\u2013353","journal-title":"Lancet Oncol"},{"key":"2720_CR13","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/archinte.164.12.1275","volume":"164","author":"Kassan","year":"2004","unstructured":"Kassan SS, Moutsopoulos HM (2004) Clinical manifestations and early diagnosis of Sj\u00f6gren syndrome. Arch Intern Med 164:1275\u20131284","journal-title":"Arch Intern Med"},{"key":"2720_CR14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/rheumatology\/39.1.97","volume":"39","author":"Makula","year":"2000","unstructured":"Makula E, Pokorny G, Kiss M et al (2000) The place of magnetic resonance and ultrasonic examinations of the parotid gland in the diagnosis and follow-up of primary Sj\u00f6gren\u2019s syndrome. Rheumatology 39:97\u2013104","journal-title":"Rheumatology"},{"key":"2720_CR15","unstructured":"Manoussakis MN, Moutsopoulos HM (1996) Antimalarials in Sj\u00f6gren\u2019s syndrome \u2013 the Greek experience. Lupus 5 [Suppl 1]:28\u201330"},{"key":"2720_CR16","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/art.20146","volume":"50","author":"Mariette","year":"2004","unstructured":"Mariette X, Ravaud P, Steinfeld S et al (2004) Inefficacy of infliximab in primary Sj\u00f6gren\u2019s syndrome: results of the randomized, controlled Trial of Remicade in Primary Sj\u00f6gren\u2019s Syndrome (TRIPSS). Arthritis Rheum 50:1270\u20131276","journal-title":"Arthritis Rheum"},{"key":"2720_CR17","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/art.510","volume":"46","author":"Petrone","year":"2002","unstructured":"Petrone D, Condemi JJ, Fife R et al (2002) A double-blind, randomized, placebo-controlled study of cevimeline in Sj\u00f6gren\u2019s syndrome patients with xerostomia and keratoconjunctivitis sicca. Arthritis Rheum 46:748\u2013754","journal-title":"Arthritis Rheum"},{"key":"2720_CR18","doi-asserted-by":"crossref","unstructured":"Routsias JG, Tzioufas AG (2010) Autoimmune response and target autoantigens in Sj\u00f6gren\u2019s syndrome. Eur J Clin Invest Jul 13. [Epub ahead of print]","DOI":"10.1111\/j.1365-2362.2010.02342.x"},{"key":"2720_CR19","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.autrev.2010.05.007","volume":"9","author":"Saraux","year":"2010","unstructured":"Saraux A (2010) The point on the ongoing B-cell depleting trials currently in progress over the world in primary Sj\u00f6gren\u2019s syndrome. Autoimmun Rev 9:609\u2013614","journal-title":"Autoimmun Rev"},{"key":"2720_CR20","doi-asserted-by":"crossref","unstructured":"Seror R, Ravaud P, Bowman S et al (2009) EULAR Sjogren\u2019s Syndrome Disease Activity Index (ESSDAI): Development of a consensus systemic disease activity index in primary Sjogren\u2019s syndrome. Ann Rheum Dis, Jun 28. [Epub ahead of print]","DOI":"10.1136\/ard.2009.110619"},{"key":"2720_CR21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1089\/jir.1998.18.255","volume":"18","author":"Shiozowa","year":"1998","unstructured":"Shiozowa S, Tanaka Y, Shiozowa K (1998) Single-blinded, controlled trial of low-dose oral IFN-\u03b1 for the treatment of xerostomia in patients with Sj\u00f6gren\u2019s syndrome. J Interferon Cytokine Res 18:255\u2013262","journal-title":"J Interferon Cytokine Res"},{"key":"2720_CR22","first-page":"1","volume":"Ophthalmol","author":"Sj\u00f6gren","year":"1933","unstructured":"Sj\u00f6gren H (1933) Zur Kenntnis der Keratoconjunctivitis sicca. Acta Ophthalmol (Suppl II):1\u2013151","journal-title":"Acta"},{"key":"2720_CR23","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/ard.2005.041186","volume":"65","author":"Theander","year":"2006","unstructured":"Theander E, Henriksson G, Ljungberg O et al (2006) Lymphoma and other malignancies in primary Sj\u00f6gren\u2019s syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 65:796\u2013803","journal-title":"Ann Rheum Dis"},{"key":"2720_CR24","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554\u2013558","journal-title":"Ann Rheum Dis"},{"key":"2720_CR25","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archinte.159.2.174","volume":"159","author":"Vivino","year":"1999","unstructured":"Vivino FB, Al-Hashimi I, Khan Z et al (1999) Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sj\u00f6gren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92\u201301 Study Group. Arch Intern Med 159:174\u2013181","journal-title":"Arch Intern Med"},{"key":"2720_CR26","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","volume":"165","author":"Zintsaras","year":"2005","unstructured":"Zintsaras E, Voulgarelis M, Moutsopoulos HM (2005) The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 165:2337\u20132344","journal-title":"Arch Intern Med"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-010-2720-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-010-2720-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-010-2720-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T22:41:48Z","timestamp":1559601708000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-010-2720-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,8]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["2720"],"URL":"https:\/\/doi.org\/10.1007\/s00108-010-2720-4","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,8]]}}}